Important news from Wellstart

Overview Abbott has announced a medical device correction affecting certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensors distributed in the United States. This action does not affect the FreeStyle Libre 14 Day, FreeStyle Libre 2, or FreeStyle Libre 2 Plus systems. Abbott identified that a subset of Libre 3 and Libre 3 Plus sensors may provide incorrect low glucose readings. While this issue does not affect every sensor, Abbott is as

We’re excited to share that the Dexcom G7 15-day continuous glucose monitor (CGM) is now available through Wellstart. This updated version of the G7 offers the same fast, accurate glucose readings patients rely on, now with a longer 15-day wear time to support convenience, fewer changes, and less waste. Dexcom has made important updates to the G7 system to support this transition, and we’re here to help you understand what’s new and what you may need to do. What’s New About